These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 20099364)
21. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. Ashton E; Raunig D; Ng C; Kelcz F; McShane T; Evelhoch J J Magn Reson Imaging; 2008 Sep; 28(3):791-6. PubMed ID: 18777526 [TBL] [Abstract][Full Text] [Related]
22. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates. Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033 [TBL] [Abstract][Full Text] [Related]
23. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299 [TBL] [Abstract][Full Text] [Related]
24. Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects. Bains LJ; McGrath DM; Naish JH; Cheung S; Watson Y; Taylor MB; Logue JP; Parker GJ; Waterton JC; Buckley DL Magn Reson Med; 2010 Aug; 64(2):595-603. PubMed ID: 20665802 [TBL] [Abstract][Full Text] [Related]
25. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK). Wechsel HW; Petri E; Bichler KH; Feil G Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199 [TBL] [Abstract][Full Text] [Related]
26. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging. Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744 [TBL] [Abstract][Full Text] [Related]
30. Limitations of the permeability-limited compartment model in estimating vascular permeability and interstitial volume fraction in DCE-MRI. Carreira GC; Gemeinhardt O; Gorenflo R; Beyersdorff D; Franiel T; Plendl J; Lüdemann L Magn Reson Imaging; 2011 Jun; 29(5):639-49. PubMed ID: 21546193 [TBL] [Abstract][Full Text] [Related]
31. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging. Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699 [TBL] [Abstract][Full Text] [Related]
32. [Characterization and staging of renal tumors: significance of MRI diagnostics]. Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837 [TBL] [Abstract][Full Text] [Related]
33. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system. Pickup S; Chawla S; Poptani H Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363 [TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation of renal tumors in the solitary kidney. Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143 [TBL] [Abstract][Full Text] [Related]
35. Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK Magn Reson Imaging; 2008 Feb; 26(2):160-70. PubMed ID: 17692490 [TBL] [Abstract][Full Text] [Related]
36. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment? Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792 [TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging measurements of vascular permeability and extracellular volume fraction of breast tumors by dynamic Gd-DTPA-enhanced relaxometry. Vincensini D; Dedieu V; Eliat PA; Vincent C; Bailly C; de Certaines J; Joffre F Magn Reson Imaging; 2007 Apr; 25(3):293-302. PubMed ID: 17371717 [TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. de Lussanet QG; Backes WH; Griffioen AW; Padhani AR; Baeten CI; van Baardwijk A; Lambin P; Beets GL; van Engelshoven JM; Beets-Tan RG Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1309-15. PubMed ID: 16125874 [TBL] [Abstract][Full Text] [Related]
39. Error estimation for perfusion parameters obtained using the two-compartment exchange model in dynamic contrast-enhanced MRI: a simulation study. Luypaert R; Sourbron S; Makkat S; de Mey J Phys Med Biol; 2010 Nov; 55(21):6431-43. PubMed ID: 20952813 [TBL] [Abstract][Full Text] [Related]
40. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study. Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]